EUCTR2005-000450-75-IT进行中（未招募）1 期
Add-on study of Olmesartan Medoximil in patients qith moderate to severe hypertension not achieving target blood pressure on Amlodipine 5mg alone.
SANKYO EUROPE0 个研究点目标入组 632 人开始时间: 2006年12月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 632
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Add-on Study of Olmesartan Medoxomil in Patients with Moderate to Severe Hypertension not Achieving Target Blood Pressure on Amlodipine 5 mg AloneEUCTR2005-000450-75-GBSankyo Pharma GmbH632
进行中（未招募）
1 期
Add-on Study of Olmesartan Medoxomil in Patients with Moderate to Severe Hypertension not Achieving Target Blood Pressure on Amlodipine 5 mg AloneEUCTR2005-000450-75-FIDaiichi Sankyo Europe GmbH1,997
进行中（未招募）
不适用
Add-on Study of Olmesartan Medoxomil in Patients with Moderate to Severe Hypertension not Achieving Target Blood Pressure on Amlodipine 5 mg AloneEUCTR2005-000450-75-BESankyo Pharma GmbH632
进行中（未招募）
不适用
Add-on Study of Olmesartan Medoxomil in Patients with Moderate to Severe Hypertension not Achieving Target Blood Pressure on Amlodipine 5 mg AloneEUCTR2005-000450-75-DESankyo Pharma GmbH632
已完成
不适用
comparison of Therapy with Olmesartan medoxomil monotherapy or azelnidipine and olmesartan medoxomil combination in hypertensive patients with chronic KIdney diseaseHypertensive patients with CKD under the treatment of the angiotensin receptor blocker(ARB), olmesartan medoxomil 20mg/dayJPRN-UMIN000004489iigata University80